Niagen Bioscience (NAGE) Revenue Growth (3y) (2014 - 2026)
Niagen Bioscience (NAGE) Revenue Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,200.25 Bn | 66,199.96 Bn | - | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.75 Bn | 466.96 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.43 Bn | 62.43 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | 79.44% |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 54.05% |
| 10 | Niagen Bioscience | 260.13 Mn | 193.58 Mn | 19.98 Mn | 11.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.75% |
| Dec 31, 2025 | 17.24% |
| Sep 30, 2025 | 25.82% |
| Jun 30, 2025 | 22.97% |
| Mar 31, 2025 | 20.88% |
| Dec 31, 2024 | 17.93% |
| Sep 30, 2024 | 13.91% |
| Jun 30, 2024 | 8.71% |
| Mar 31, 2024 | 14.69% |
| Dec 31, 2023 | 11.13% |
| Sep 30, 2023 | 11.19% |
| Jun 30, 2023 | 9.96% |
| Mar 31, 2023 | 16.28% |
| Dec 31, 2022 | 17.06% |
| Sep 30, 2022 | 12.28% |
| Jun 30, 2022 | 14.66% |
| Mar 31, 2022 | 19.76% |
| Dec 31, 2021 | 25.12% |
| Sep 30, 2021 | 28.70% |
| Jun 30, 2021 | 31.39% |